Delivery of chimeric hepatitis B core particles into liver cells

Aims:  To display a liver‐specific ligand on the hepatitis B virus core particles for cell‐targeting delivery.

[1]  B. Tey,et al.  Purification of His-tagged hepatitis B core antigen from unclarified bacterial homogenate using immobilized metal affinity-expanded bed adsorption chromatography. , 2010, Journal of chromatography. A.

[2]  Junjie Xu,et al.  [Hepatitis B virus core protein as an epitope vaccine carrier: a review]. , 2010, Sheng wu gong cheng xue bao = Chinese journal of biotechnology.

[3]  Byung O. Lee,et al.  Use of hepadnavirus core proteins as vaccine platforms , 2009, Expert review of vaccines.

[4]  C. Sureau,et al.  The Pre-S1 and Antigenic Loop Infectivity Determinants of the Hepatitis B Virus Envelope Proteins Are Functionally Independent , 2009, Journal of Virology.

[5]  B. Tey,et al.  N-terminally His-tagged hepatitis B core antigens: construction, expression, purification and antigenicity. , 2009, Journal of virological methods.

[6]  W. Tan,et al.  Display of hepatitis B virus PreS1 peptide on bacteriophage T7 and its potential in gene delivery into HepG2 cells. , 2009, Journal of virological methods.

[7]  Chien-Hsun Wu,et al.  A Novel Peptide Enhances Therapeutic Efficacy of Liposomal Anti-Cancer Drugs in Mice Models of Human Lung Cancer , 2009, PloS one.

[8]  W. Tan,et al.  Recombinant hepatitis B virus core particles: association, dissociation and encapsidation of green fluorescent protein. , 2008, Journal of virological methods.

[9]  I. Yacoby,et al.  Killing cancer cells by targeted drug-carrying phage nanomedicines , 2008, BMC biotechnology.

[10]  A. L. Amaral,et al.  Quantification of the CBD-FITC conjugates surface coating on cellulose fibres , 2008, BMC biotechnology.

[11]  M. Nassal,et al.  Development of hepatitis B virus capsids into a whole-chain protein antigen display platform: new particulate Lyme disease vaccines. , 2008, International journal of medical microbiology : IJMM.

[12]  W. Tan,et al.  Interactions of hepatitis B core antigen and peptide inhibitors. , 2007, Journal of Medicinal Chemistry.

[13]  M. Walkinshaw,et al.  Crystallization and X-ray analysis of the T = 4 particle of hepatitis B capsid protein with an N-terminal extension. , 2007, Acta crystallographica. Section F, Structural biology and crystallization communications.

[14]  S. Urban,et al.  Viral and cellular determinants involved in hepadnaviral entry. , 2007, World journal of gastroenterology.

[15]  A. Kondo,et al.  Gene therapy of liver tumors with human liver-specific nanoparticles , 2007, Cancer Gene Therapy.

[16]  N. Abdullah,et al.  Heat treatment of unclarified Escherichia coli homogenate improved the recovery efficiency of recombinant hepatitis B core antigen. , 2006, Journal of virological methods.

[17]  K. Cao,et al.  Expression and purification of the synthetic preS1 gene of Hepatitis B Virus with preferred Escherichia coli codon preference. , 2006, Protein expression and purification.

[18]  B. Böttcher,et al.  Hepatitis B Virus Capsid-like Particles Can Display the Complete, Dimeric Outer Surface Protein C and Stimulate Production of Protective Antibody Responses against Borrelia burgdorferi Infection* , 2006, Journal of Biological Chemistry.

[19]  Y. Shaul,et al.  Clathrin-mediated Endocytosis and Lysosomal Cleavage of Hepatitis B Virus Capsid-like Core Particles* , 2006, Journal of Biological Chemistry.

[20]  M. Nassal,et al.  In vitro assembly of mosaic hepatitis B virus capsid‐like particles (CLPs): Rescue into CLPs of assembly‐deficient core protein fusions and FRET‐suited CLPs , 2005, FEBS letters.

[21]  Akihiko Kondo,et al.  The specific delivery of proteins to human liver cells by engineered bio‐nanocapsules , 2005, The FEBS journal.

[22]  Y. Wang,et al.  Expression and purification of the complete PreS region of hepatitis B Virus. , 2005, World journal of gastroenterology.

[23]  Y. Shaul,et al.  Recombinant viral capsids as an efficient vehicle of oligonucleotide delivery into cells. , 2005, Biochemical and biophysical research communications.

[24]  P. Pumpens,et al.  Mosaic hepatitis B virus core particles presenting the complete preS sequence of the viral envelope on their surface. , 2004, The Journal of general virology.

[25]  A. Kondo,et al.  Nanoparticles for the delivery of genes and drugs to human hepatocytes , 2003, Nature Biotechnology.

[26]  W. Tan,et al.  Hepatitis B Virus Core Antigen: Enhancement of Its Production in Escherichia coli, and Interaction of the Core Particles with the Viral Surface Antigen , 2003, Biological chemistry.

[27]  W. Tan,et al.  Production of the Nucleocapsid Protein of Newcastle Disease Virus in Escherichia coli and its Assembly into Ring- and Nucleocapsid-like Particles , 2001 .

[28]  D. Raimondo,et al.  N-terminal myristylation of HBV preS1 domain enhances receptor recognition. , 2001, The journal of peptide research : official journal of the American Peptide Society.

[29]  I. Park,et al.  Purification and structural analysis of the hepatitis B virus preS1 expressed from Escherichia coli. , 2001, Biochemical and biophysical research communications.

[30]  B. Yélamos,et al.  Cloning, expression, and purification of histidine-tagged preS domains of hepatitis B virus. , 2001, Protein expression and purification.

[31]  B. Böttcher,et al.  Native display of complete foreign protein domains on the surface of hepatitis B virus capsids. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  W. Tan,et al.  Two distinct segments of the hepatitis B virus surface antigen contribute synergistically to its association with the viral core particles. , 1999, Journal of molecular biology.

[33]  P. Galle,et al.  Myristylation of the large surface protein is required for hepatitis B virus in vitro infectivity. , 1996, Virology.

[34]  C. Guguen-Guillouzo,et al.  Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity. , 1995, Virology.

[35]  Yan-Xin Liu,et al.  Expression and characterization of the preS1 peptide of hepatitis B surface antigen in Escherichia coli , 1991, Journal of medical virology.

[36]  D. Ganem,et al.  Assembly of hepadnaviral virions and subviral particles. , 1991, Current topics in microbiology and immunology.

[37]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.